secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2026-07-07T12:45:22+00:00
Accession:  0001437749-26-022880
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key regains Nasdaq compliance; trading resumes July 8 after hearing panel decision
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel determined BIO-key regained compliance with minimum bid price and SEC filing requirements.
- Trading of BKYI common stock resumes on Nasdaq Capital Market on July 8, 2026.
- Company subject to Discretionary Panel Monitor for one year until July 6, 2027.
- CEO cites growing recurring revenue, solid financial position, and expects significantly improved results in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926022880/0001437749-26-022880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926022880/bkyi20260706c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-022880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer